+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group



Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group



Primary Care 7(1): 175-179



Data from the five-year follow-up of the 2789 men in the placebo group of the Coronary Drug Project indicate that serum cholesterol level elevation and cigarette smoking, both remediable factors, adversely affect morbidity and mortality following recovery from myocardial infarction. Although the most powerful predictive factors of mortality from coronary heart disease were those related to the status of the myocardium (selected electrocardiographic changes, cardiomegaly, New York Heart Association functional classification), these features are basically irremediable. These observations suggest that benefit may ensue from measures that can safely reduce elevated serum cholesterol levels or lead to cessation of smoking or both and that use of these two interventions appears prudent in patients recovered from myocardial infarction. Data regarding hypertension are less clear; at present the evidence would suggest that management of mild hypertension following myocardial infarction should give emphasis to sodium restriction and reduction of weight, when appropriate.

(PDF emailed within 1 workday: $29.90)

Accession: 044847408

Download citation: RISBibTeXText

PMID: 6992178


Related references

Natural history of myocardial infarction in the coronary drug project: long-term prognostic importance of serum lipid levels. Coronary Drug Project Research Group. American Journal of Cardiology 42(3): 489-498, 1978

Cigarette smoking as a risk factor in men with a prior history of myocardial infarction. The Coronary Drug Project Research Group. Journal of Chronic Diseases 32(6): 415-425, 1979

The coronary drug project aspirin study. Implications for clinical care. Coronary Drug Project Research Group. Primary Care 5(1): 91-95, 1978

Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group. Circulation 63(6): 1342-1350, 1981

Practical aspects of decision making in clinical trials: the coronary drug project as a case study. The Coronary Drug Project Research Group. Controlled Clinical Trials 1(4): 363-376, 1981

The Coronary Drug Project: methods and lessons of a multicenter clinical trial. Coronary Drug Project Research Group. Controlled Clinical Trials 4(4): 1-541, 1983

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. JAMA 220(7): 996-1008, 1972

Blood pressure in survivors of myocardial infarction. The Coronary Drug Project Research Group. Journal of the American College of Cardiology 4(6): 1135-1147, 1984

The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA 226(6): 652-657, 1973

Coronary drug project: experience with niacin. Coronary Drug Project Research Group. European Journal of Clinical Pharmacology 40 Suppl 1: S49-S51, 1991

The coronary drug project relationship between coronary risk factors and prognosis for survival after recovery from previous myo cardial infarction. Circulation 40(4-S3): 62, 1969

The risk of cigarette smoking in men with a prior history of myo cardial infarction results from the coronary drug project. American Journal of Epidemiology 106(3): 237, 1977

Factors influencing long-term prognosis after recovery from myocardial infarction--three-year findings of the coronary drug project. Journal of Chronic Diseases 27(6): 267-285, 1974

Aspirin in coronary heart disease. The Coronary Drug Project Research Group. Journal of Chronic Diseases 29(10): 625-642, 1976

The natural history of coronary heart disease prognostic factors after recovery from myo cardial infarction in the coronary drug project. Circulation Supplement: Ii-193, 1978